August J. Moretti
2017 - DepoMed
In 2017, August J. Moretti earned a total compensation of $1.7M as Chief Financial Officer and Senior Vice President at DepoMed, a 4% decrease compared to previous year.
Compensation breakdown
| Option Awards | $395,102 |
|---|---|
| Salary | $435,873 |
| Stock Awards | $895,070 |
| Other | $6,612 |
| Total | $1,732,657 |
Moretti received $895.1K in stock awards, accounting for 52% of the total pay in 2017.
Moretti also received $395.1K in option awards, $435.9K in salary and $6.6K in other compensation.
Rankings
In 2017, August J. Moretti's compensation ranked 6,215th out of 14,666 executives tracked by ExecPay. In other words, Moretti earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,215 out of 14,666 | 58th |
Division Manufacturing | 2,282 out of 5,772 | 61st |
Major group Chemicals And Allied Products | 723 out of 2,075 | 65th |
Industry group Drugs | 559 out of 1,731 | 68th |
Industry Pharmaceutical Preparations | 441 out of 1,333 | 67th |
Source: SEC filing on March 27, 2018.
Moretti's colleagues
We found five more compensation records of executives who worked with August J. Moretti at DepoMed in 2017.